Novel targeted therapies and immunotherapy for advanced thyroid cancers GE Naoum, M Morkos, B Kim, W Arafat Molecular cancer 17, 1-15, 2018 | 237 | 2018 |
Timing of lymphedema after treatment for breast cancer: when are patients most at risk? SGR McDuff, AI Mina, CL Brunelle, L Salama, LEG Warren, ... International Journal of Radiation Oncology* Biology* Physics 103 (1), 62-70, 2019 | 181 | 2019 |
Quantifying the impact of axillary surgery and nodal irradiation on breast cancer–related lymphedema and local tumor control: long-term results from a prospective screening trial GE Naoum, S Roberts, CL Brunelle, AM Shui, L Salama, K Daniell, ... Journal of Clinical Oncology 38 (29), 3430-3438, 2020 | 109 | 2020 |
Single stage direct-to-implant breast reconstruction has lower complication rates than tissue expander and implant and comparable rates to autologous reconstruction in patients … GE Naoum, L Salama, A Niemierko, BL Vieira, Y Belkacemi, AS Colwell, ... International Journal of Radiation Oncology* Biology* Physics 106 (3), 514-524, 2020 | 89 | 2020 |
Journey of TRAIL from bench to bedside and its potential role in immuno-oncology GE Naoum, DJ Buchsbaum, F Tawadros, A Farooqi, WO Arafat Oncology Reviews 11 (1), 2017 | 50 | 2017 |
The impact of chest wall boost on reconstruction complications and local control in patients treated for breast cancer GE Naoum, L Salama, A Ho, NK Horick, O Oladeru, M Abouegylah, ... International Journal of Radiation Oncology* Biology* Physics 105 (1), 155-164, 2019 | 48 | 2019 |
Subclinical lymphedema after treatment for breast cancer: risk of progression and considerations for early intervention LK Bucci, CL Brunelle, MC Bernstein, AM Shui, TC Gillespie, SA Roberts, ... Annals of Surgical Oncology 28 (13), 8624-8633, 2021 | 31 | 2021 |
Evaluation of radiation-induced cardiac toxicity in breast cancer patients treated with Trastuzumab-based chemotherapy M Abouegylah, LZ Braunstein, MA Alm El-Din, A Niemierko, L Salama, ... Breast cancer research and treatment 174, 179-185, 2019 | 30 | 2019 |
Risk of developing breast reconstruction complications: a machine-learning nomogram for individualized risk estimation with and without postmastectomy radiation therapy GE Naoum, AY Ho, A Shui, L Salama, S Goldberg, W Arafat, J Winograd, ... Plastic and Reconstructive Surgery 149 (1), 1e-12e, 2022 | 24 | 2022 |
Integrating symptoms into the diagnostic criteria for breast cancer–related lymphedema: applying results from a prospective surveillance program CL Brunelle, SA Roberts, NK Horick, TC Gillespie, JM Jacobs, KM Daniell, ... Physical Therapy 100 (12), 2186-2197, 2020 | 24 | 2020 |
Role of nanotechnology and gene delivery systems in TRAIL-based therapies GE Naoum, F Tawadros, AA Farooqi, MZ Qureshi, S Tabassum, ... Ecancermedicalscience 10, 2016 | 24 | 2016 |
Optimal breast reconstruction type for patients treated with neoadjuvant chemotherapy, mastectomy followed by radiation therapy GE Naoum, OT Oladeru, A Niemierko, L Salama, J Winograd, A Colwell, ... Breast Cancer Research and Treatment 183, 127-136, 2020 | 23 | 2020 |
Patients who report cording after breast cancer surgery are at higher risk of lymphedema: results from a large prospective screening cohort CL Brunelle, SA Roberts, AM Shui, TC Gillespie, KM Daniell, GE Naoum, ... Journal of surgical oncology 122 (2), 155-163, 2020 | 21 | 2020 |
Weight loss does not decrease risk of breast cancer–related arm lymphedema SA Roberts, TC Gillespie, AM Shui, CL Brunelle, KM Daniell, JJ Locascio, ... Cancer 127 (21), 3939-3945, 2021 | 17 | 2021 |
Survivin a radiogenetic promoter for glioblastoma viral gene therapy independently from CArG motifs GE Naoum, ZB Zhu, DJ Buchsbaum, DT Curiel, WO Arafat Clinical and Translational Medicine 6, 1-11, 2017 | 16 | 2017 |
Radiation modality (proton/photon), timing, and complication rates in patients with breast cancer receiving 2-stages expander/implant reconstruction GE Naoum, MI Ioakeim, AM Shui, L Salama, A Colwell, AY Ho, ... Practical radiation oncology 12 (6), 475-486, 2022 | 15 | 2022 |
Endocrine treatment for 5 years or radiation for 5 days for patients with early breast cancer older than 65 years: can we do it right? GE Naoum, AG Taghian Journal of Clinical Oncology 41 (13), 2331-2336, 2023 | 14 | 2023 |
Comparison between standard and reduced volume radiotherapy in bladder preservation trimodality protocol for muscle-invasive bladder cancer patients W Arafat, A Darwish, GE Naoum, W Sameh, G El Husseiny, ... ecancermedicalscience 10, 2016 | 14 | 2016 |
Targeted radiotherapy potentiates the cytotoxicity of a novel anti-human DR5 monoclonal antibody and the adenovirus encoding soluble TRAIL in prostate cancer W Arafat, T Zhou, GE Naoum, DJ Buchsbaum Journal of the Egyptian National Cancer Institute 27 (4), 205-215, 2015 | 13 | 2015 |
Incidence of peripheral edema in patients receiving PI3K/mTOR/CDK4/6 inhibitors for metastatic breast cancer KM Daniell, A Bardia, F Sun, SA Roberts, CL Brunelle, TC Gillespie, ... Breast Cancer Research and Treatment 175, 649-658, 2019 | 10 | 2019 |